Comparison of the effects of edoxaban, an oral factor Xa inhibitor, and other anticoagulants on thrombin generation

被引：0
|
作者：
Mendell, J. [1 ]
Li, Y. [1 ]
Samama, M. M. [2 ]
Halim, A-B [1 ]
Song, S. [1 ]
Depasse, F. [3 ]
Kunitada, S. [4 ]
机构：
[1] Daiichi Sankyo Pharma Dev, Edison, NJ USA
[2] Hosp Hotel Dieu, Paris, France
[3] Biomnis Lab, Ivry, France
[4] Daiichi Sankyo Co Ltd, Tokyo, Japan
来源：
JOURNAL OF THROMBOSIS AND HAEMOSTASIS | 2011年 / 9卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
P-WE-176
引用
收藏
页码：575 / 575
页数：1
相关论文
共 50 条
  • [41] Thrombin generation in children on oral anticoagulants
    Greenway, A.
    Ignjatovic, V
    Summerhayes, R.
    Newall, F.
    Burgess, J.
    DeRosa, L.
    Monagle, P.
    JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2009, 7 : 466 - 466
  • [42] Successful Treatment With the Oral Factor Xa Inhibitor Edoxaban in Heparin-Induced Thrombocytopenia With Thrombosis
    Porres-Aguilar, Mateo
    Najera, Carolina
    Mares, Adriana C.
    Benzidia, Ilham
    Prakash, Swathi
    Crichi, Benjamin
    ANGIOLOGY, 2023,
  • [43] A Direct Oral Factor Xa Inhibitor Edoxaban Ameriorates Hepatic Ischemia-Reperfusion Injury
    Maeda, K.
    Kuriyama, N.
    Sakamoto, T.
    Kaluba, B.
    Yuge, T.
    Noguchi, D.
    Ito, T.
    Gyoten, K.
    Hayasaki, A.
    Fujii, T.
    Iizawa, Y.
    Murata, Y.
    Tanemura, A.
    Kishiwada, M.
    Mizuno, S.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2023, 23 (06) : S914 - S915
  • [44] Melagatran, a direct thrombin inhibitor, but not edoxaban, a direct factor Xa inhibitor, nor heparin aggravates tissue factor-induced hypercoagulation in rats
    Furugohri, Taketoshi
    Fukuda, Toshio
    Tsuji, Naoki
    Kita, Akemi
    Morishima, Yoshiyuki
    Shibano, Toshiro
    EUROPEAN JOURNAL OF PHARMACOLOGY, 2012, 686 (1-3) : 74 - 80
  • [45] Comparison of antithrombotic efficacy between edoxaban, a direct factor Xa inhibitor, and fondaparinux, an indirect factor Xa inhibitor under low and high shear rates
    Fukuda, Toshio
    Tsuji, Naoki
    Honda, Yuko
    Kamisato, Chikako
    Morishima, Yoshiyuki
    Shibano, Toshiro
    THROMBOSIS AND HAEMOSTASIS, 2011, 106 (06) : 1062 - 1068
  • [46] Oral direct thrombin inhibitors or oral factor Xa inhibitors versus conventional anticoagulants for the treatment of pulmonary embolism
    Li, Meixuan
    Li, Jing
    Wang, Xiaoqin
    Hui, Xu
    Wang, Qi
    Xie, Shitong
    Yan, Peijing
    Tian, Jinhui
    Li, Jianfeng
    Xie, Ping
    Yang, Kehu
    Yao, Liang
    COCHRANE DATABASE OF SYSTEMATIC REVIEWS, 2023, (04):
  • [47] A Thorough Electrocardiogram Study of Edoxaban, a Novel Factor Xa Inhibitor
    Mendell, J.
    Basavapathruni, R.
    Swearingen, D.
    Draves, A.
    Zhang, G.
    Morganroth, J.
    JOURNAL OF CLINICAL PHARMACOLOGY, 2011, 51 (08): : 1241 - 1246
  • [48] Combination effects of edoxaban, an oral direct factor Xa inhibitor, and P2Y12 receptor antagonists on ADP plus tissue-factor induced thrombin generation in human platelet-rich plasma
    Morishima, Y.
    Honda, Y.
    JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2013, 11 : 821 - 821
  • [49] Novel anticoagulants based an direct inhibition of thrombin and factor Xa
    Gardell, SJ
    Sanderson, PEJ
    CORONARY ARTERY DISEASE, 1998, 9 (2-3) : 75 - 81
  • [50] Chapter 8. Anticoagulants: Inhibitors of thrombin and factor Xa
    Sanderson, PEJ
    ANNUAL REPORTS IN MEDICINAL CHEMISTRY, VOL 36, 2001, 36 : 79 - 88
12345